STOCKS TELEGRAPH

Author: Mustafa Bin Tariq

  • Albemarle Corporation (ALB) stock declined on Friday. Here’s why

    The stock of Albemarle Corporation (ALB) closed the regular trading session at $ 179.07, losing 3.9% from the previous trading session. On the last check, the ALB stock declined -0.60% to $178 in the after-market. The stock price kept moving between $175.11 and $184.88. ALB declared that its executive would take part in the virtual conference. The company also filed the form 10-K/A with SEC on 2 March 2022.

    Albemarle Corporation is a chemical substance-producing organization. It works in 3 segments: lithium, bromine, and catalysts. Starting in 2020, Albemarle was the biggest supplier of lithium for EV batteries. The firm has a market capitalization of $20.96 billion with 117.04 million pending shares. ALB has its base in Charlotte, North Carolina, United States of America (USA).

    News

    Albemarle Corporation (ALB) declared that the CEO of the company, Kent Masters, and CFO of the firm, Scott Tozier, will take part in the forthcoming virtual conference organized by the RBC Capital Market. The conference will commence on 8 March 2022.

    Also, on 24 February 2022, ALB proclaimed the dividend on its shares. The company revealed the quarterly dividend to be $0.395 for each stock. Moreover, this year points to Albemarle’s 28th sequential year increasing its profit.

    ALB Financials

    Albemarle Corporation (ALB) published the fiscal performance for Q4 and FY21, on 16 February 2022. The key points are

    • Total revenue of $894.2 million in Q4 of FY21 versus $879.1 million in Q4 of FY20. This marks an increase of 1.17%. Moreover, total revenue in 2021 expanded by 6.3% to $3.3 billion from $3.1 billion in 2020.
    • ALB had a total income of $10.4 million in Q4 of FY21 compared to $102.1 million in the same period last year. Also, the firm had a net income of $199.9 million in 2021 against $446.6 million in 2020.
    • Loss of $0.03 per stock in Q4 of FY21. Also, EPS of $1.06 in FY2021.

  • OceanPal Inc (OP) stock is soaring in the after-market. Here’s why

    The stock of OceanPal Inc (OP) closed the regular trading session at $0.625, gaining 13.66% from the previous trading session. On the last check, the stock of OP remained bullish in the after-market, gaining 14.4% to $0.715. OP stock kept moving between $0.53 and $0.69. The company declared the agreement for m/v Calipso. OP also filed for form 6-K with the SEC on 2 March 2022.

    OceanPal Inc. is a worldwide supplier of ocean-going transportation administrations. The firm’s vessels at present covey a bunch of dry mass cargoes. This includes products such as iron metal, coal, grain, and different materials along overall delivery paths. Currently, OceanPal Inc (OP) has a fleet of 2 Panamax carriers that include 1 protef and 6 calipso. Also, the company has a capsize carrier which includes one in Salt Lake City. OP has a market capitalization of $5.51 million with 8.82 million shares pending. The company has its headquarter in Athens, Greece.

    OP News

    On 2 March 2022, the firm declared to have entered a time contract for m/v Calipso, with another shipping company, Tongli Shipping. m/v Calipso is a Panamax dry vessel of Tongli Shipping. The total agreement charge is $24,500 each day. The mediator will get a 5% portion, for a time of 90 days. The contract will begin on March 9, 2022. The m/v Calipso is at present leased, at a gross contract charge of $17,850 each day, and a 5% commission paid to the mediator. The utilization of Calipso will produce roughly $2.21 million of total income for the booked time of the contract.

    It is anticipated that the OP’s vessels will be fundamentally utilized for a brief time and expedition sanctions following the finishing of their current jobs.

    Also, OP will hold a conference call for its investors on 31 March 2022.

  • CTI BioPharma Corp (CTIC) stock is soaring in the pre-market. Here’s the reason

    The stock of CTI BioPharma Corp (CTIC) closed the regular trading session at $3.95, gaining 17.21% from the previous day’s trading session. On the last check, the stock of CTIC remained bullish in the pre-market and gained 3.04% to $4.07. The firm provided an update about the approval of VONJO by the FDA. The company also filed form 8-K with the SEC on 2 March 2022.

    News

    On 28 February 2022, CTIC provided an update for the compliance of VONJO by the FDA. VONJO is a medicine that is used in the therapy of myelofibrosis and thrombocytopenia in adults. The firm made an announcement that the FDA has accepted the VONJA to treat the victim with a low count of platelets. The suggested dose of VONJO is 200 mg by mouth, two times a day. VONJO is the initial therapy that explicitly orates the necessities of victims with myelofibrosis. The sped-up endorsement depends on the adequacy outcome from the critical Phase 3 investigation of VONJO in victims with myelofibrosis. The common side effects include nausea, and diarrhea, while the serious side effects include heart failure and pneumonia.

    The CEO of CTI BioPharma (CTIC), Adam R. Craig, stated that in the U.S., there are around 21,000 patients with myelofibrosis, 66% of which have cytopenia’s. He further added that we anticipate giving VONJO for cytopenic myelofibrosis treatment to the patients in 10 days. Moreover, Mr. Craig concluded that he is grateful to the CTI group for the persistent efforts, dedication, and emphasis on the requirements of victims.

    About CTIC

    CTI BioPharma Corp is a biopharmaceutical organization, which centers around the production, possession, and advertisation of novel designated treatments for blood cancers. Also, the firm has a market cap of $381.93 million with 96.69 million shares pending. CTIC has its base in Seattle, Washington, United States of America (USA).

  • DBV Technologies S.A. (DBVT) stock plunged in the pre-market. Here’s why

    The stock of DBV Technologies S.A. (DBVT) lost 20.00% in the pre-market to $1.40 after releasing the fiscal performance for FY2021. DBVT stock closed the regular trading session at $1.75, gaining 34.62% from the previous day’s trading session. The stock kept moving between $1.44 and $1.75. DBV Technologies also filed form 8-K with the SEC on 3 March 2022.

    DBV Technologies SA is a biopharmaceutical firm known for creating “Viaskin” innovation. It regulates the allergens or antigens to unblemished skin while keeping away from any movement to the blood. The company has a market cap of $96.14 million with 54.94 million pending shares. DBVT has its headquarter in Mont rouge, France.

    DBVT’s key financials

    On 3 March 2022, DBV Technologies released the fiscal performance for FY2021. The firm’s sales for FY21 reduced by 49.3% to $5.7 million in 2021 from $11.2 million in 2020. DBVT had the expense from the operation of $104.3 million in 2021 versus $170.1 million in 2020. This marks a contraction of 38.6% in the expenses from operations. Moreover, the firm reported a total loss of $97.8 million in 2021 against $159.5 million in 2020. The total loss declined by 38.6%. Also, the loss of $1.78 per stock in 2021 is compared to the loss of $2.95 per stock in 2020. The loss per stock also declined by 39.6%. Moreover, as of December 31, 2021, DBVT had total assets worth $146.7 million of which cash and cash equivalents were $77.3 million.

    CEO Remarks

    The CEO of DBVT, Daniel Tasse, commented that starting the new Phase 3 preliminary with the mVP is their main concern. They are satisfied with the continuous discussions with FDA. He further added that they expect this financial position will give DBV an adequate chance to acquire an alliance with FDA on the convention for the mVP essential preliminary.

    Further, Mr. Tasse concluded that they expect to understand the maximum capacity of the Viaskin innovation for patients and families.

  • Puma Biotechnology Inc (PBYI) stock is gaining in the pre-market. Here’s why

    The stock of Puma Biotechnology Inc (PBYI) closed the regular trading session at $2.33, gaining 4.95% from the previous trading session. On the last check, PBYI stock remained bullish, gaining 8.58% to $2.53, in the pre-market. The firm published the fiscal performance for Q4 and FY21. PBYI also filed the form 10-K and 8-K with the SEC on 3 March 2022.

    PBYI key financials

    On 3 March 2022, Puma (PBYI) published its financial performance for Q4 and FY2021, which concluded on 31 December 2021. The main highlights of fiscal performance are

    • PBYI had the total sales of $55.4 million in Q4 of FY21 versus $52.6 million in Q4 of FY20. This marks a growth of 5.3%. Also, the sales in 2021 expanded by 12.4% to $253.2 million against $225.1 million in 2020. Further, the total sales beat the estimates by 16.14%.
    • The firm had an operative income of $6.8 million versus the operative loss of $11.3 million in the same period last year. Also, PBYI had an operative income of $1.3 million in 2021 against the operative loss of $30.4 million in 2020.
    • The company had a total income of $4.2 million in Q4 of FY21 versus the total loss of $15 million in the same period of last year. Also, the total loss for 2021 was $29.1 million in comparison to $60 million in 2020, reducing by 51.5%.
    • Moreover, the EPS of $0.10 in Q4 of FY21 versus the loss of $0.38 per share. Also, the loss of $0.72 per stock in 2021. The EPS in Q4 of FY21 exceeded the estimate of a loss of $0.11 per stock.

    CEO Remarks:

    The CEO of PBYI stated that during the final quarter of 2021 Puma accomplished its crucial achievements. They incorporated the introduction of information from the preliminary summit at the 2021 San Antonio Breast Cancer Symposium. He further added that they were satisfied to declare the augmentation of 5 extra years to the U.S. patent term of NERLYNX in the quarter too.

    Mr. Auerbach concluded that they stay focused on furnishing neratinib to the victims with HER2 positive breast malignant growth.

  • Payoneer Global Inc (PAYO) stock is losing in the after-market. Here’s why

    The stock of Payoneer Global Inc (PAYO) closed the regular trading session at $4.24, losing 6.19% from the previous trading session. On the last check, the stock kept on following the bearish trend, further losing 4.01% in the after-market, to $4.07. PAYO stock kept oscillating between $4.20 and $4.54, in the recent trading session. The company released the fiscal performance for Q4 and FY21. Payoneer also filed the form 10-K and 8-K with the SEC on 3 March 2022.

    Payoneer is a financial administrations organization that gives online cash transfers, digital payments and provides clients with working capital. Account-holders can send and get money utilizing an e-wallet. The organization represents considerable authority in working with cross-line B2B payments. Payoneer has a market cap of $1.44 billion and 339.01 million pending shares. The firm has its base in New York, United States of America (USA).

    PAYO’s key financials

    On 3 March 2022, Payoneer Global Inc (PAYO) released the fiscal performance for Q4 and FY21, which concluded on 31 December 2021. The key financials of the firm are:

    • The sales of PAYO expanded by 46.9% in Q4 of FY21 to $139.2 million from $94.7 million in the same period of last year. Also, the sales in 2021 grew by 36.9% to $473.4 million from $345.5 in 2020.
    • Moreover, the loss by operations was reduced in Q4 of FY21 by 55.5% to $4.1 million from $9.4 million in the same year-ago period. Also, the loss from operation expanded by 74.6% to $30.2 million in 2021 from $17.2 million in 2020.
    • PAYO had a total loss of $18.9 million in Q4 of FY21 versus $11.2 million in Q4 of FY20. This marks an increase of 68.5%. Further, the total loss in 2021 was $33.9 million against $23.7 million in 2020, expanding by 43.1%.
    • The company had a loss of $0.06 and $0.33 per stock in Q4 and FY21, respectively.

    FY2022 stance

    Payoneer (PAYO) estimates the revenue for FY2022 to be in the range of $530 million to $540 million.

    CEO Remarks

    The CEO of PAYO, Scott Galit, commented that they had an amazing Q4, conveying income and Adjusted EBITDA better than their assumptions. He further said that given their solid position, they are very much hopeful for their future.

    Mr Galit concluded that they are amped up for the growth and the positive returns they are creating from their investments as they keep on extending their wide scope of services.

  • Weave Communications Inc (WEAV) stock lost 25.72% in the pre-market. Here’s why

    Weave Communications Inc (WEAV) stock lost 25.72% in the pre-market. Here’s why

    The stock of Weave Communications Inc (WEAV) closed the regular trading session at $9.33, losing 2.51% from the previous trading session. On the last check, the WEAV stocked remained bearish in the pre-market, losing 25.72% to $6.93. The company released the fiscal performance for Q4 and FY21. WEAV also filed form 8-K with SEC on 2 March 2022. The form refers to the current report.

    Weave Communications Inc (WEAV) is an organization that is focused on the software market. WEAV deals in selling the subscription for its communication platform, which consolidates programming and analysis apparatuses with cloud-based phone administrations. The firm has a market cap of $58.95 million and 62.91 million pending shares. Weave communications have its headquarter in Lehi, Utah, United States of America (USA).

    WEAV’s key financials

    On 2 March 2022, WEAV released the fiscal performance for Q4 and FY21, which ended on 31 December 2021. The key financials of the firm are

    • The sales of WEAV saw a growth of 33.9% to $31.8 million in Q4 of FY21 from $23.7 million in Q4 of FY20. Moreover, sales for 2021 expanded by 45% to $115.8 million from $79.8 million in 2020.
    • The total profit of the company grew by 31.3% from $13.8 million in Q4 of FY20 to $18.1 million in Q4 of FY21. Also, the profit in 2021 was $66.4 million versus $45.5 million in 2020. This marks an expansion of 46.3%
    • Weave reported a loss of $14.06 million in Q4 of FY21 compared to $9.3 million in the same period last year. Further, the yearly loss increased by 27.8% to $51.6 million in 2021 from $40.4 million in 2020.
    • Moreover, the loss of $0.34 and $2.60 per stock in Q4 and FY21, respectively.

    The CEO of Weave Communications (WEAV), Roy Banks, commented that in 2021, they kept on serving their vertical business sectors which showed amazing development and strength as reflected in their 45% expansion in yearly income. Mr. Banks further added that they have carried out another Go-To-Market technique intended to extend and advance their deals to accomplish long-haul development in a commercial center.

    Fiscal 2022 stance

    WEAV estimated the sales for Q1 of FY22 to be in the range of $31 million to $32 million. Also, the firm expects the sales for FY22 to be in the range of $136 million and $140 million.

  • Ross Stores Inc (ROST) stock losing in the after-market. Here’s why

    Ross Stores Inc (ROST) stock losing in the after-market. Here’s why

    The stock of Ross Stores Inc (ROST) closed the regular trading session at $95, gaining 6.09% from the previous trading session. ROST stock lost 0.02% in the after-hours to $94.98, on the last check. Ross stores published the fiscal performance for Q4 and FY21. The firm filed form 8-K with the SEC on 1 March 2022 to report the fiscal performance.

    ROST’s key financials

    On 1 March 2022, Ross stores published the fiscal performance for Q4 and FY21. The key financials of the firm are

    • ROST’s sales expanded by 18.1% from $4.2 billion in Q4 of FY20 to $5.02 billion in Q4 of FY21. Moreover, the sales for 2021 grew by 50.9% to $18.9 billion from $12.5 billion in 2020.
    • The total earning of ROST increased by 54.1% to $366.8 million in Q4 of FY21 from $237.9 million in the same period last year. Also, the earnings for 2021 grew massively to $1.72 billion from $85.3 million in 2020.
    • The firm had an EPS of $1.04 and $4.87 in Q4 and FY21, respectively.
    • As of 29 January 2022, the firm had cash and cash equivalents of $4.93 billion versus $4.81 billion on 30 January 2021.

    The CEO of Ross Stores (ROST), Barbara Rentler, said that they accomplished a solid outcome for Q4 in spite of the adverse consequence from Omicron cases and supply-chain blockage.

    Fiscal 2022 stance

    ROST estimates the revenue growth of 3% against 13% growth in FY21. The firm also estimated the EPS for FY22 to be in the range of $4.71 and $5.12 versus $4.87 in FY21. ROST expects the EPS for Q1 of FY22 to be between $0.93 and $0.99 compared to $1.34 in the corresponding period of last year.

    ROST News

    The stock buyback program was approved by the BoD of ROST. Under the buyback program, the firm will reclaim the stocks worth $1.9 billion. The Board additionally expanded the quarterly dividend by 9% to $0.31 per stock.

    About ROST

    Ross Stores Inc, working under the name Ross Dress for Less, is an American chain of discounted retail chains settled in Dublin, California. The firm has a market capitalization of $33.57 billion with 353.33 million shares pending.

  • Vuzix Corporation (VUZI) stock is losing in the pre-market. Here’s why

    Vuzix Corporation (VUZI) stock is losing in the pre-market. Here’s why

    The stock of Vuzix Corporation (VUZI) closed the recent trading session at $5.68, gaining 3.84% from the previous trading session. VUZI stock declined in the after-market, losing 1.06% to $5.62, in the after-market. The stock kept moving between $4.89 and $5.70 during the regular trading session. Vuzix published the fiscal performance for Q4 and FY21. The firm also filed for form 10-K with the SEC. The form refers to the annual report of the firm.

    VUZI’s key financials

    Vuzix Corporation published the fiscal performance for Q4 and FY21, on 1 March 2022. The key components of the performance are

    • VUZI’s sales dropped by 21.7% in the Q4 of FY21 to $3.3 million from $4.2 million in the same year-ago period. Also, yearly sales were up by 13.6% in 2021 to $13.1 million from $11.5 million in 2020.
    • The firm had a total profit of $0.20 million in Q4 of FY21 versus $0.70 million in the same period of last year. This marks a reduction of 70.2%. Further, yearly profit expanded by 27.1% in 2021 to $2.4 million from $1.9 million in 2020.
    • The total loss grew by 373.7% from $3.5 million in Q4 of FY20 to $17.01 million in Q4 of FY21. Moreover, yearly loss also expanded by 124.9% from $17.9 million in 2020 to $40.3 million in 2021.
    • Loss of $0.27 and $0.66 per stock in Q4 and FY21, respectively.

    The CEO of Vuzix, Paul Travers, commented that it was the year of huge headway for them concerning industry validation and organizational growth. He further added that they effectively began their sales channel, which drove the growth of AR before new clients.

    Moreover, Mr. Travers concluded that they have made a strong monetary record, as they grow their capacities and worldwide impression to fulfill the needs of customers.

    News

    On 2 March 2022, VUZI declared the buyback program of their shares approved by the BoD. The amount of buyback under the program is $25 million. The program expired on 2 March 2022. Further, under the program of shares buyback, stocks of the firm might be repurchased intermittently in the open market or private exchanges. Moreover, established by the closing price of Vuzix’s stock on 1 March 2022, the program would empower the organization to repurchase roughly 4 million stocks or around 6% of its shares.

    About VUZI

    Vuzix Corp. is a provider of Smart-Glasses and AR advancements and items for the buyer. The company has a market cap of $261.42 million with 63.63 million pending shares. Vuzix has its headquarter in West Henrietta, New York, United States of America (USA).

  • PLBY Group Inc (PLBY) stock is down in the after-market. Here’s the reason

    PLBY Group Inc (PLBY) stock is down in the after-market. Here’s the reason

    The stock of PLBY Group Inc (PLBY) closed the regular trading session at $16.42, gaining 12.31% from the previous trading session. PLBY stock lost 2.44% in the after-market, following the release of financial performance for Q4 and FY21. The stock kept oscillating between $15.02 and $16.90. The firm filed for the form NT 10-K and 8-K with the SEC. The forms refer to the late submission of form 10-K and annual report, respectively.

    PLBY Group Inc is a worldwide media and lifestyle organization. It was established by Hugh Hefner as Playboy Enterprises to supervise the Playboy magazine and related resources. The firm has a market capitalization of $695.06 million with 42.33 million shares pending. Moreover, PLBY has its headquarter in Los Angeles, California, United States of America (USA).

    PLBY’s financials

    On 1 March 2022, PLBY released the fiscal performance for Q4 and FY21, which ended on 31 December 2021. The total sales expanded by 106.5% in Q4 of FY21 to $95.6 million from $46.3 million in Q4 of FY20. Further, yearly sales grew by 66.9% in 2021 to $246.5 million from $147.6 million in 2020. Also, the firm had a loss from operations of $56.1 million in Q4 of FY21 versus the income from operations of $4.9 million in Q4 of FY20. Moreover, the loss from operations in 2021 was $69.6 million versus the income from operations of $13.6 million in 2020.

    The total loss of the company in Q4 of FY21 expanded massively to $58.1 million from $0.51 million in Q4 of FY20. Further, the total loss for 2021 expanded to $79.7 million from $5.2 million in 2020. The firm reported a loss of $1.33 and $2.09 per stock in Q4 and FY21, respectively.

    The CEO of PLBY Group, Ben Kohn, stated that 2021 was a heavenly year for their organization. The firm had $247 million in yearly income, three acquisitions, the inauguration of their blockchain items. He further added that this year they are collecting the pieces obtained in 2021 to make an adaptable establishment for their changing business.